Greenberger, P.A., Clinical aspects of allergic bronchopulmonary aspergillosis. Front Biosci 8 (2003), s119–s127.
Stevens, D.A., Schwartz, H.J., Lee, J.Y., Moskovitz, B.L., Jerome, D.C., Catanzaro, A., et al. A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis. N Engl J Med 342 (2000), 756–762.
Laoudi, Y., Paolini, J.B., Grimfed, A., Just, J., Nebulised corticosteroid and amphotericin B: an alternative treatment for ABPA?. Eur Respir J 31 (2008), 908–909.
Godet, C., Meurice, J.C., Roblot, F., Kauffmann-Lacroix, C., Verdaguer, M., Frat, J.P., et al. Efficacy of nebulised liposomal amphotericin B in the attack and maintenance treatment of ABPA. Eur Respir J 39 (2012), 1261–1263.
Li, J.X., Fan, L.C., Li, M.H., Cao, W.J., Xu, J.F., Beneficial effects of omalizumab therapy in allergic bronchopulmonary aspergillosis: a synthesis review of published literature. Respir Med 122 (2017), 33–42.
Burgel, P.R., Paugam, A., Hubert, D., Martin, C., Aspergillus fumigatus in the cystic fibrosis lung: pros and cons of azole therapy. Infect Drug Resist 9 (2016), 229–238.
Bel, E.H., Wenzel, S.E., Thompson, P.J., Prazma, C.M., Keene, O.N., Yancey, S.W., et al. Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma. N Engl J Med 371 (2014), 1189–1197.
Schleich, F., Brusselle, G., Louis, R., Vandenplas, O., Michils, A., Pilette, C., et al. Heterogeneity of phenotypes in severe asthmatics. The Belgian Severe Asthma Registry (BSAR). Respir Med 108 (2014), 1723–1732.
Agarwal, R., Sehgal, I.S., Dhooria, S., Aggarwal, A.N., Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis. Expert Rev Respir Med 10 (2016), 1317–1334.
Haldar, P., Brightling, C.E., Hargadon, B., Gupta, S., Monteiro, W., Sousa, A., et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 360 (2009), 973–984.
Terashima, T., Shinozaki, T., Iwami, E., Nakajima, T., Matsuzaki, T., A case of allergic bronchopulmonary aspergillosis successfully treated with mepolizumab. BMC Pulm Med, 18, 2018, 53.
Oda, N., Miyahara, N., Senoo, S., Itano, J., Taniguchi, A., Morichika, D., et al. Severe asthma concomitant with allergic bronchopulmonary aspergillosis successfully treated with mepolizumab. Allergol Int 67 (2018), 521–523.
Soeda, S., To, M., Kono, Y., Yamawaki, S., Tsuzuki, R., Katsube, O., et al. Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab. Allergol Int 68 (2019), 377–379.
Hirota, S., Kobayashi, Y., Ishiguro, T., Nishida, T., Kagiyama, N., Shimizu, Y., et al. Allergic bronchopulmonary aspergillosis successfully treated with mepolizumab: case report and review of the literature. Respir Med Case Rep 26 (2018), 59–62.
Tsubouchi, H., Tsuchida, S., Yanagi, S., Shigekusa, T., Miura, M., Sakaguchi, K., et al. Successful treatment with mepolizumab in a case of allergic bronchopulmonary aspergillosis complicated with nontuberculous mycobacterial infection. Respir Med Case Rep, 28, 2019.
Matsumoto, N., Shigekusa, T., Matsuo, A., Tsubouchi, H., Yanagi, S., Nakazato, M., Allergic bronchopulmonary aspergillosis complicated by eosinophilic chronic rhinosinusitis successfully treated with mepolizumab. Respirol Case Rep, 7, 2019, e00465.
